1Matthew E,Patra F,Koletsi K,et a1.The diversity of definitionsof multi drug-resistant(MDR)and pan drug resistant(PDR) Acinetobacter baumannii and Pseudomonas aeruginosa[J].J Med Microbio,2006,55:1619.
4Bonomo RA,Szabo D.Mechanisms of multidrug resistance in Acinetobacter species and Pseudomonas aeruginosa[J].Clin Infect Dis,2006,43:49.
5Poirel L,Nordmann P.Carbapenem resistance in Acinetobacter baumannii:mechanisms and epidemiology[J].Clin Microbiol Infect,2006,12:826.
6Peleg AY,Adams J,Paterson DL.Tigecycline efflux as a mechanism for nonsusceptibility in Acinetobacter baumannii[J].Antimicrob Agents Chemother,2007,51:2065.
7Betrosian AP,Frantzeskaki F,Xanthaki A,et al.High-dose ampicillinsulbactamas an alternative treatment oflate-onset VAP from multidrug-resistant Acinetobacter baumannii[J].Scand J Infect Dis,2007,39:38.
8Betrosian AP,Frantzeskaki F,Xanthaki A,et al.Efficacy and safety of high-dose ampicillin/sulbactam vs.colistin as monotherapy for the treatment of multidrug resistant Acinetobacter baumannii ventilator-associatedpneumonia[J].Infect,2008,56:432.
9Lee NY,Wang CL,Chuang YC,et al.Combination carbapenem-sulbactam therapy for critically ill patients with multidrugresistant Acinetobacter baumannii bacteremia:four case reports and an in vitro combination synergy study[J].Pharmacotherapy,2007,27:1506.
4Clinical and Laboratory Standards Institute. 2005. Performance standards for antimicrobial susceptibility testing; fifteenth informational supplement. Clinical and Laboratory Standards Institute, Wayne, Pa.
5Tenover FC, Arbeit RD, Goering RV, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbial,1995, 33 : 2233-2239.
6Levesque C, Piche L, Larose C, et al. PCR mapping of integrons reveals several novel combination of resistance genes. Antimicrob Agents Chemother, 1995, 39 : 185-191.
7Jeon BC, Jeong H, Bae K, et al. Investigation of a nosocomial outbreak of imipenem-resistant Acinetobacter baumannii producing OXA-23 β-lactamase in Korea. J Clin Microb, 2005, 43:2241-2245.
8Dalla-Costa LM, Coelho JM, Souza HAPHM, et al. Outbreak of carbapenem-resistant Acinetobacter baumannii producing the OXA-23 enzyme in Curitiba, Brazil. J Clin Microb, 2003, 41:3403-3406.
9Villers D, Espase E, Coste-Burel M, et al. Nosocomial Acinetobacter baumannii infections: microbiological and clinical epidemiology. Ann Intern Med, 1998, 129: 182-189.
10Manikal VM, Landman D, Saurina G, et al. Endemic carbapenem-resistant Acinetobacter species in Brooklyn, New York.- citywide prevalence, interinstitutional spread, and relation to antibiotic usage. Clin Infect Dis, 2000, 31 : 101-106.
